| Dr Todd E Williams, MD | |
|
2300 E 30th St Bldg B, Ste 103, Farmington, NM 87401-8991 | |
| (505) 327-1754 | |
| (505) 327-1840 |
| Full Name | Dr Todd E Williams |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 32 Years |
| Location | 2300 E 30th St Bldg B, Farmington, New Mexico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124110283 | NPI | - | NPPES |
| B7802 | Medicaid | NM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0122X | Surgery - Plastic And Reconstructive Surgery | 2000-312 (New Mexico) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| San Juan Regional Medical Center | Farmington, NM | Hospital |
| Entity Name | Todd Williams, Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619060274 PECOS PAC ID: 6800961160 Enrollment ID: O20080820000729 |
News Archive
Sinapis Pharma is pleased to announce that it has received notice from the FDA that its Investigational New Drug application (IND) for the use of IV methamphetamine for acute stroke was approved on April 9, 2010. "We have accomplished a great deal of work for a small company on a very tight budget. We have GMP drug ready for the Phase I clinical trial and the Phase I site is prepared to begin this protocol," said Dr. Donald Picker , the company CEO.
Children under age 5 who underwent minor surgery requiring anesthesia had a 26 percent increased risk of later diagnosis with a mental disorder. However, the timing of the procedure did not affect this risk, according to a new study at Columbia University's Mailman School of Public Health and College of Physicians and Surgeons.
Rush University Medical Center is participating in a National Institutes of Health (NIH) study to determine the best course of treatment to reduce the risk of stroke patients suffering another stroke.
The U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) today awarded a contract to develop an antibiotic that could be used against possibly two types of bioterrorism as well as common infections that are becoming resistant to antibiotics.
PCI Biotech (PCIB) the Norwegian biopharmaceutical company, reported today that the first patient has been included in the phase II study of Amphinex in combination with the cytotoxic agent bleomycin in head and neck cancer patients, called the ENHANCE study. The first patient was included at the National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Germany. NCT is a joint project of the German Cancer Research Center (DKFZ), Heidelberg University Hospital, Thoraxklinik Heidelberg and Deutsche Krebshilfe (German Cancer Aid).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Todd E Williams, MD Po Box 5820, Farmington, NM 87499-5820 Ph: (505) 327-1754 | Dr Todd E Williams, MD 2300 E 30th St Bldg B, Ste 103, Farmington, NM 87401-8991 Ph: (505) 327-1754 |
News Archive
Sinapis Pharma is pleased to announce that it has received notice from the FDA that its Investigational New Drug application (IND) for the use of IV methamphetamine for acute stroke was approved on April 9, 2010. "We have accomplished a great deal of work for a small company on a very tight budget. We have GMP drug ready for the Phase I clinical trial and the Phase I site is prepared to begin this protocol," said Dr. Donald Picker , the company CEO.
Children under age 5 who underwent minor surgery requiring anesthesia had a 26 percent increased risk of later diagnosis with a mental disorder. However, the timing of the procedure did not affect this risk, according to a new study at Columbia University's Mailman School of Public Health and College of Physicians and Surgeons.
Rush University Medical Center is participating in a National Institutes of Health (NIH) study to determine the best course of treatment to reduce the risk of stroke patients suffering another stroke.
The U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) today awarded a contract to develop an antibiotic that could be used against possibly two types of bioterrorism as well as common infections that are becoming resistant to antibiotics.
PCI Biotech (PCIB) the Norwegian biopharmaceutical company, reported today that the first patient has been included in the phase II study of Amphinex in combination with the cytotoxic agent bleomycin in head and neck cancer patients, called the ENHANCE study. The first patient was included at the National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Germany. NCT is a joint project of the German Cancer Research Center (DKFZ), Heidelberg University Hospital, Thoraxklinik Heidelberg and Deutsche Krebshilfe (German Cancer Aid).
› Verified 7 days ago
Raul Rivet, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 555 S Schwartz Ave, Farmington, NM 87401 Phone: 505-564-8073 Fax: 505-324-2259 | |
Dr. David W Mccray, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 622 W Maple St, Suite C, Farmington, NM 87401 Phone: 505-327-9694 Fax: 505-327-7524 | |
Dr. Dennis J Robison, M.D. Surgery Medicare: May Accept Medicare Assignments Practice Location: 622 W Maple St, Suite C, Farmington, NM 87401 Phone: 505-327-9694 Fax: 505-327-7524 | |
Dr. Paul Richard Cutler, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 801 West Maple, San Juan Regional Medical Center, Farmington, NM 87401 Phone: 505-609-2451 | |
Dr. David Alan Dunworth, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 802 E Navajo St, Farmington, NM 87401 Phone: 505-215-1120 Fax: 505-327-6060 | |
Maureen Mannas, MD Surgery Medicare: Medicare Enrolled Practice Location: 735 W Animas St, Farmington, NM 87401 Phone: 505-609-6300 Fax: 505-599-4636 |